How much funding has GlowDx raised?

GlowDx has raised $1.2M in total funding, most recently a Seed round.

Who are GlowDx's investors?

GlowDx's investors include Angel investors, SOSV.

Where is GlowDx headquartered?

GlowDx is headquartered in Cork, Ireland.

What industry is GlowDx in?

GlowDx operates in Biotech, Healthcare.

GlowDx

Democratizing access to molecular diagnostics

Cork, Ireland · Founded 2015 · $1.2M raised

Biotech

Healthcare

Headquarters: Cork
Employees: 11–50
Founded: 2015
Business Model: B2B

Website: glowdx.com
Total Funding: $1.2M
Last Round: $1.1M SeedJul 2020
Rounds: 2

About

GlowDx is an Irish molecular diagnostics company founded in 2015 by Blaine Doyle and Yensi Flores Bueso, students from UCC's MSc in Molecular Cell Biology with Bioinnovation. The company is developing a point-of-care (POC) diagnostics platform using novel molecular science to provide developing countries with high-quality diagnostic tests for infectious diseases. GlowDx participated in the RebelBio accelerator and received recognition at the Irish Business Youth Entrepreneur Awards. The platform aims to tackle neglected tropical diseases and improve epidemiology surveillance in resource-limited settings.

Summary

GlowDx is a Biotech company based in Cork, Ireland, founded in 2015. It has raised $1.2M in total across 2 rounds, most recently a $1.1M Seed round in Jul 2020. Investors include Angel investors and SOSV.